Selective N2-Alkylation of 1H-Indazoles and 1H-Azaindazoles

Abstract

A general and selective procedure for the N2-alkylation of 1H-indazoles and 1H-azaindazoles is presented. Promoted by either trifluoromethanesulfonic acid or copper(II) triflate, diverse 1H-indazoles/azaindazoles are selectively alkylated with varied primary, secondary, and tertiary alkyl 2,2,2-trichloroacetimidates at the N2-nitrogen to afford the corresponding 2-alkyl-2H-indazoles/azaindazoles. Forty-one examples are included along with a discussion of reaction optimization, scope, and mechanism.

Key words

regioselectivity - indazoles - alkylation - trichloroacet­imidates - azaindazoles

• References

• 1a Shrivastava A, Chakraborty AK, Upmanyu N, Singh A. Austin J. Anal. Pharm. Chem. 2016; 3: 1076
• 1b Hassan AA, Aly AA, Tawfeek HN. Adv. Heterocycl. Chem. 2018; 125: 235
• 1c Zhang SG, Liang CG, Zhang WH. Molecules 2018; 23: 2783
• 2a Fludzinski P, Evrard DA, Bloomquist WE, Lacefield WB, Pfeifer W, Jones ND, Deeter JB, Cohen ML. J. Med. Chem. 1987; 30: 1535
• 2b Marfat A. PCT Int. Appl WO 1999023077, 1999
• 2c Bamborough P, Angell RM, Bhamra I, Brown D, Bull J, Christopher JA, Cooper AW, Fazal LH, Giordano I, Hind L, Patel VK. Bioorg. Med. Chem. Lett. 2007; 17: 4363
• 2d Feng Y, Cameron MD, Frackowiak B, Griffin E, Lin L, Ruiz C, Schröter T, LoGrasso P. Bioorg. Med. Chem. Lett. 2007; 17: 2355
• 2e Gaikwad DD, Chapolikar AD, Devkate CG, Warad KD, Tayade AP, Pawar RP, Domb AJ. Eur. J. Med. Chem. 2015; 90: 707
• 3 A SciFinder^® structural search finds 278,000 structural entities with a 1H-indazole vs 180,000 for 2H-indazole.
• 4 Cadogan JI. G, Cameron-Wood M, Mackie RK, Searle RJ. G. J. Chem. Soc. 1965; 4831
• 5a Akazome M, Kondo T, Watanabe Y. J. Chem. Soc., Chem. Commun. 1991; 1466
• 5b Rajanarendar E, Reddy AS. R, Shaik FP. Indian J. Chem., Sect. B: Org. Chem. Incl. Med. Chem. 2008; 47B: 1591
• 5c Creencia EC, Kosaka M, Muramatsu T, Kobayashi M, Iizuka T, Horaguchi T. J. Heterocycl. Chem. 2009; 46: 1309
• 5d Okuro K, Gurnham J, Alper H. Tetrahedron Lett. 2012; 53: 620
• 5e Moustafa AH, Malakar CC, Aljaar N, Merisor E, Conrad J, Beifuss U. Synlett 2013; 24: 1573
• 5f Genung NE, Wei L, Aspnes GE. Org. Lett. 2014; 16: 3114
• 5g Wu T.-Y, Dhole S, Selvaraju M, Sun C.-M. ACS Comb. Sci. 2018; 20: 156
• 5h Kaur M, Kumar R. ChemistrySelect 2018; 3: 5330
• 5i Zhu JS, Li CJ, Tsui KY, Kraemer N, Son J.-H, Haddadin MJ, Tantillo DJ, Kurth MJ. J. Am. Chem. Soc. 2019; 141: 6247
• 6a Stokes BJ, Vogel CV, Urnezis LK, Pan M, Driver TG. Org. Lett. 2010; 12: 2884
• 6b Kumar MR, Park A, Park N, Lee S. Org. Lett. 2011; 13: 3542
• 6c Hu J, Cheng Y, Yang Y, Rao Y. Chem. Commun. 2011; 47: 10133
• 6d Shi DQ, Dou G.-L, Ni SN, Shi JW, Li XY, Wang X.-S, Wu H, Ji S.-J. Synlett 2007; 2509
• 6e Sun F, Feng X, Zhao X, Huang Z.-B, Shi D.-Q. Tetrahedron 2012; 68: 3851
• 6f Lian Y, Bergman RG, Lavis LD, Ellman JA. J. Am. Chem. Soc. 2013; 135: 7122
• 6g Li H, Li P, Zhao Q, Wang L. Chem. Commun. 2013; 49: 9170
• 6h Fang Y, Wu C, Larock RC, Shi F. J. Org. Chem. 2011; 76: 8840
• 6i Schoene J, Bel Abed H, Schmieder P, Christmann M, Nazaré M. Chem. Eur. J. 2018; 24: 9090
• 6j Rai GS, Maru JJ. Chem. Heterocycl. Compd. 2020; 56: 973
• 7a Cheung M, Boloor A, Stafford JA. J. Org. Chem. 2003; 68: 4093
• 7b Mei Y, Yang B. Indian J. Heterocycl. Chem. 2017; 27: 275
• 7c Baddam SR, Kumar NU, Reddy AP, Bandichhor R. Tetrahedron Lett. 2013; 54: 1661
• 8 Lin MH, Liu HJ, Lin WC, Kuo CK, Chuang TH. Org. Biomol. Chem. 2015; 13: 11376
• 9a Luo G, Chen L, Dubowchik G. J. Org. Chem. 2006; 71: 5392
• 9b Slade DJ, Pelz NF, Bodnar W, Lampe JW, Watson PS. J. Org. Chem. 2009; 74: 6331
• 10 Mou XQ, Chen XY, Chen G, He G. Chem. Commun. 2018; 54: 515
• 11 See Supporting Information.
• 12 Cran JW, Vidhani DV, Krafft ME. Synlett 2014; 25: 1550
• 13a Catalán J, de Paz JL. G, Elguero J. J. Chem. Soc., Perkin Trans. 2 1996; 57
• 13b Minkin VI, Garnovskii DG, Elguero J, Katritzky AR, Denisko OV. Adv. Heterocycl. Chem. 2000; 76: 157
• 14 Churcher I, Hunt P, Nanthakumar CB, Simpson PB. Preparation of 3-(indol-2-yl)indazole derivatives for treatment of Alzheimer’s disease. August 9, 2007, WO 2007088401A1.